Corteva v. Inari: In Seed Patent Trial Set to Impact Industry’s Future, Corteva Seeks to Illustrate Grand Plot While Inari Highlights Cracks in the Foundations

Corteva Agriscience (CTVA) went to trial today in its lawsuit against Inari Agriculture that accuses the biotech startup of infringing on several corn and soybean seed patents—a dispute that raises sector-defining issues including public access to inventions and barriers to entry in a highly concentrated market

Member States Consider Proposal to Give EU More Powers Under Tech Sovereignty Bill

As EU member states start discussions on the bloc’s main proposal to reduce its reliance on U.S. tech, Danish officials want to give the European Commission more powers to designate the cloud...

Sep 24, 2026 Read Now >

Health Care Weekly: Corcept Seeks Dismissal of Off-Label Marketing Whistleblower Suit; Medicare ACCESS Program to Cover More Chronic Conditions; FDA Launches Accelerated Investigational Drug Review Program; Agencies Announce Fresh Steps to Curb Animal Testing; Abbott Settles Federal Claims of Formula Contamination

The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. Key stories we’re following this week...

Sep 23, 2026 Read Now >

Apple To Face Fresh EU Penalty Under Digital Markets Rules, Sources Say

The European Commission is preparing to hit Apple (AAPL) with its second fine under the EU’s digital markets rules as soon as this year, according to two sources familiar with the matter. The...

Sep 23, 2026 Read Now >

Corteva v. Inari: In Seed Patent Trial Set to Impact Industry’s Future, Corteva Seeks to Illustrate Grand Plot While Inari Highlights Cracks in the Foundations

RELATED ARTICLES | Antitrust Policy

Member States Consider Proposal to Give EU More Powers Under Tech Sovereignty Bill

Apple To Face Fresh EU Penalty Under Digital Markets Rules, Sources Say

FILTER BY

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.